Die US-Anleger treten nach einer ereignisreichen Woche auf die Bremse: Die Zinserhöhung der Fed, Höchststände bei den Energiepreisen und hartnäckige Inflationssorgen verpassen der Euphorie um Künstliche Intelligenz einen Dämpfer.
Um Verbraucher in der Spritkrise zu unterstützen, kündigen Bund und Länder zunächst einen teuren Rabatt mit der Gießkanne, danach neuartige Preisgrenzen an. Die beste Lösung funktioniert technisch noch nicht.
Die US-Börsen haben den Freitag überwiegend ruhig beendet. Unterstützung kam erneut von den niedrigeren Ölpreisen. Die wieder steigenden Renditen amerikanischer Staatsanleihen sorgten dagegen kaum für Unruhe. Auch der große Verfall an den Terminmärkten hinterließ am Aktienmarkt keine deutlich erkennbaren Spuren.
Sheeran’s supporting acts and backing band withdrew from his North American tour after rapper Macklemore was barred from opening for Sheeran at multiple venues following remarks supporting Palestinian people.
PARSIPPANY, N.J., Sept. 18, 2026 (GLOBE NEWSWIRE) -- Teva Pharmaceuticals, a U.S. affiliate of Teva Pharmaceutical Industries Ltd. (NYSE and TASE: TEVA), today announced new data from a discrete choice experiment highlighting preferred healthcare provider (HCP) treatment attributes when selecting a VMAT2 inhibitor for the treatment of TD in older patients (aged ?55 years). The new findings were presented at Psych Congress, held September 15 – 19, 2026, in New Orleans, LA.
PARSIPPANY, N.J., Sept. 18, 2026 (GLOBE NEWSWIRE) -- Teva Pharmaceuticals, a U.S. affiliate of Teva Pharmaceutical Industries Ltd. (NYSE and TASE: TEVA), today announced new real-world data evaluating treatment continuity, healthcare resource utilization (HCRU) and clinical outcomes among adults with schizophrenia and bipolar I disorder (BD-I) treated with UZEDY (risperidone) extended-release injectable suspension. The results demonstrate how UZEDY helps patients with schizophrenia remain on t...
Democratic Senate candidates entered summer with a cash edge, while Trump-linked groups now pour money into increasingly crowded and costly ad markets.
PARSIPPANY, N.J., Sept. 18, 2026 (GLOBE NEWSWIRE) -- Teva Pharmaceuticals, a U.S. affiliate of Teva Pharmaceutical Industries Ltd. (NYSE and TASE: TEVA), today announced the presentation of new olanzapine LAI (TEV-749) post hoc data from the pivotal SOLARIS Phase 3 trial as well as analyses supporting treatment switch strategies. The SOLARIS data highlighted the acute and long-term durability, efficacy and safety of TEV-749 as a once-monthly subcutaneous long-acting injectable (LAI) formulat...
OpenAI Chief Executive Sam Altman will brief the United Nations Security ?Council next week during the annual gathering of world leaders in New York for the UN General Assembly, an OpenAI spokesperson said on Friday.
This under-the-radar industrial technology stock boasts a Superscore of 88 from our Hidden Gems Primary database, part of The Motley Fools Moneyball Database system. Heres why.
CEO Dr. Lior Shaltiel and R&D Director Dr. Tali Kizhner to engage with industry, investors and scientific leaders during a concentrated week in Boston CEO Dr. Lior Shaltiel and R&D Director Dr. Tali Kizhner to engage with industry, investors and scientific leaders during a concentrated week in Boston
The US and China are discussing a plan to reduce or eliminate Chinas tariffs on American LNG as part of a broader package of energy and agriculture agreements that could be announced when Chinese President Xi Jinping visits Washington next week, according to two people briefed ?on the discussions.
Ford is paying a dividend while its turnaround plays out. Stellantis is still working toward positive free cash flow and doesnt expect to get there until 2027. The difference in financial footing tells the whole story.
WALTHAM, Mass., Sept. 18, 2026 (GLOBE NEWSWIRE) -- Zenas BioPharma, Inc. (“Zenas” or the “Company”) (Nasdaq: ZBIO), a clinical-stage global biopharmaceutical company committed to being a leader in the development and commercialization of transformative therapies for patients living with autoimmune and inflammatory diseases, today announced that on September 15, 2026 (the “Grant Date”), the Compensation Committee of the Company’s Board of Directors granted non-qualified stock options to purchas...
Underscores Enact’s Continued Strong Performance and Robust Capital Position Underscores Enact’s Continued Strong Performance and Robust Capital Position
EXTON, Pa., Sept. 18, 2026 (GLOBE NEWSWIRE) -- Omega Flex, Inc. (the “Company”) today announced that the Board of Directors declared a regular quarterly dividend of $0.34 per share payable on October 14, 2026, to shareholders of record on September 30, 2026. In determining the amount of future regular quarterly dividends, the Board will review the cash needs of the Company, and based on results of operations, financial condition, capital expenditure plans, and consideration of possible acquisi...
NINGBO, China--(BUSINESS WIRE)--Allied Biofuels hat im Büro von Sinopec in Ningbo (China) eine wichtige Besprechung zur FEED-Planung (Front-End Engineering Design) abgehalten. Daran nahmen Allied Biofuels sowie die wichtigsten internationalen Engineering- und Technologieanbieter teil, die das auf 6,1 Milliarden US-Dollar veranschlagte und durch ein Präsidialdekret unterstützte Projekt für nachhaltigen Flugkraftstoff (SAF) und e-SAF in Usbekistan begleiten: Sinopec Engineering Group Co., Ltd. (C
NEW YORK (dpa-AFX Analyser) - Die kanadische Bank RBC hat Volkswagen (VW) nach einer deutlichen Gewinnwarnung auf "Outperform" mit einem Kursziel von 120 Euro belassen. Die Konsensschätzungen enthielten bereits etliche der aktuellen Ankündigungen des Autobauers, die Einfluss auf das operative Ergebnis (Ebit) und den freien Barmittelzufluss hätten, schrieb Tom Narayan am Freitag in einer ersten Reaktion. [mehr]
WUXI, China, Sept. 18, 2026 (GLOBE NEWSWIRE) -- LOBO TECHNOLOGIES LTD. (Nasdaq: LOBO) (“LOBO” or the “Company”), an innovative electric mobility vehicles manufacturer and seller, today announced its unaudited financial results for the first half of fiscal year 2026 ended June 30, 2026.
VENLO, Niederlande--(BUSINESS WIRE)--QIAGEN N.V. (NYSE: QGEN; Frankfurt Prime Standard: QIA) hat heute bekannt gegeben, dass am 6. November 2026 um 14:00 Uhr MEZ eine Außerordentliche Hauptversammlung stattfinden wird. Die Aktionärinnen und Aktionäre werden über die Bestellung von Jonathan M. Pratt in die Geschäftsführung von QIAGEN abstimmen, nachdem er seine Position als Chief Executive Officer (CEO) von QIAGEN am 1. September 2026 angetreten hatte. Vorbehaltlich der Zustimmung der Aktionärin
HAMBURG, Germany and AUSTIN, Texas, Sept. 18, 2026 (GLOBE NEWSWIRE) -- XCHG Limited (“XCharge” or the “Company”) (Nasdaq: XCH), a global provider in high-power EV charging solutions, today reported its unaudited financial results for the six months ended June 30, 2026.
The developer of solid-state batteries for electric vehicles reported a notable insider sale, in which the executive completely exited holdings in family trusts.
After 26 years at Telemundo, the Emmy Award-winning broadcaster makes the move to the streaming platform, bringing his signature "¡GOOOOL!" call with him.
Hims & Hers advertises $199/month for compounded semaglutide as part of a 6-month prepaid plan. Several low-cost providers offer month-to-month semaglutide from $189–$299 with no upfront commitment. GLP-1 weight loss starts at $129/mo Provider-reviewed options. No membership fees. See if you qualify ?
A new study focused on previously untested leguminous crops, specifically organic green bush beans, exploring thirteen different solar shading to increase revenue.
Bad Marienberg (www.aktiencheck.de) - Die Aktie von Hut 8 Corp. (ISIN: US44812J1043, WKN: A3ES40, Ticker-Symbol: V71, NASDAQ-Symbol: HUT) erhält kräftigen Rückenwind von der Wall Street: Wells Fargo nimmt die Beobachtung des Unternehmens mit dem Rating "overweight" und einem Kursziel von 175 USD auf. [mehr]
Die Aktie des US-Sportartikelhersteller Nike befindet sich weiterhin auf Talfahrt. Innerhalb der vergangenen 52 Wochen hat sich der Kurs bereits mehr als halbiert. Und die jüngsten Zahlen und Meldungen des Konzerns machen aktuell eher wenig Mut, dass in Kürze die Trendwende eingeleitet wird – eher im Gegenteil.
One company is growing a commercial drug business with limited margin for error on the path to profitability. The other has a platform that proved itself at global scale and keeps finding new diseases to target.